BioNTech vaccine: Company to seek emergency clearance in US on Friday, CEO says
[ad_1] Sahin said the company will file documents for the emergency use of the vaccine with the United States Food and Drug Administration (FDA). A final analysis of the phase 3 trial of the vaccine shows that it was 95% effective in preventing infections, even in older adults, and did not pose any serious safety … Read more